SXTC logo

SXTC

Profile

Full Name

China SXT Pharmaceuticals, Inc.

Ticker Symbol

SXTC

Exchange

NASDAQ

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Country

China

IPO

January 4, 2019

Indexes

Not included

Website

http://www.sxtchina.com

Employees

75

Key Details

Price

$2.16(+118.40%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$1.93M(-2.19% YoY)

Annual EPS

-$28.58(+83.93% YoY)

PE ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$2.16
SXTC price is $2.16

30-Day Relative Volume

28.94
SXTC 30-day relative volume is 28.94

Price Performance

Price Most recent change

+118.4%
SXTC price was up +118.4% on Apr 17, 2025

Price YTD change

+325.2%
SXTC price is up +325.2% since January 1st

Price 1-year change

+83.05%
SXTC price is up +83.05% year-on-year

Price 3-year change

-60.73%
SXTC price is down -60.73% over the past 3 years

Price Range

Price All-time high

$2335.00
SXTC price is currently -99.91% below its historical high of $2335.00

Price 3-year low

$0.30
SXTC price is currently +620.00% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$29.73M
SXTC market capitalization is $29.73 million

Market cap 3-year change

+52892.39%
SXTC market capitalization is up +52892.39% over the past 3 years

Market cap All-time high

$42.39M
SXTC market capitalization is currently -29.87% below its historical high of $42.39 million

Market cap sector rank

31.36%
SXTC market capitalization is higher than 31.36% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+4863.32%
SXTC shares outstanding is up +4863.32% year-on-year

Shares Outstanding 3-Year Change

+134834.31%
SXTC shares outstanding is up +134834.31% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.45
SXTC beta is 0.45

200-day SMA

$1.11
SXTC price is currently +95.46% above its 200-day simple moving average

50-day SMA

$2.46
SXTC price is currently -12.02% below its 50-day simple moving average

RSI

46.92
SXTC 14-day relative strength index is 46.92

Volume

28.94
SXTC 30-day relative volume is 28.94

ATR

$0.47
SXTC average true range is $0.47

10-day Historical Volatility

688.46%
SXTC 10-day historical volatility is 688.46%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$1.93M
SXTC annual revenue is $1.93 million

Revenue Analysts estimate

-
SXTC annual revenue consensus analysts' forecast is unknown

Revenue 1-year change

-2.19%
SXTC annual revenue is down -2.19% year-on-year

Revenue Sector rank

15.25%
SXTC annual revenue is higher than 15.25% of companies in Healthcare sector

EPS

EPS

-$28.58
SXTC annual earnings per share is -$28.58

EPS Analysts estimate

-
SXTC annual earnings per share consensus analysts' forecast is unknown

EPS 1-year change

+83.93%
SXTC annual earnings per share is up +83.93% year-on-year

EPS Sector rank

5.39%
SXTC annual earnings per share is higher than 5.39% of companies in Healthcare sector

Profit

Gross profit

$554.00K
SXTC annual gross profit is $554.00 thousand

Gross margin

28.73%
SXTC annual gross profit margin is 28.73%

Operating profit

-$2.52M
SXTC annual operating income is -$2.52 million

Operating margin

-130.42%
SXTC annual operating profit margin is -130.42%

Net income

-$3.10M
SXTC annual net profit is -$3.10 million

Net margin

-160.67%
SXTC annual net profit margin is -160.67%

Expenses

Total expenses

$4.44M
SXTC annual total expenses is $4.44 million

Operating expenses

$3.07M
SXTC annual total operating expenses is $3.07 million

Cost of goods sold

$1.37M
SXTC annual cost of goods sold is $1.37 million

Selling, general & administrative expenses

$3.07M
SXTC annual SGA is $3.07 million

Depreciation and amortization

$203.20K
SXTC annual depreciation & amortization is $203.20 thousand

Interest expense

$544.30K
SXTC annual interest expense is $544.30 thousand

Income tax

$0.00
SXTC annual income tax is $0.00

EBIT & EBITDA

EBIT

-$2.55M
SXTC annual earnings before interest & taxes is -$2.55 million

EBITDA

-$2.35M
SXTC annual EBITDA is -$2.35 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$23.13M
SXTC annual total assets is $23.13 million

Non current assets

$8.89M
SXTC annual long term assets is $8.89 million

Current assets

$14.23M
SXTC annual total current assets is $14.23 million

Cash and cash equivalents

$12.07M
SXTC annual cash & cash equivalents is $12.07 million

Accounts receivable

$1.31M
SXTC annual accounts receivable is $1.31 million

Inventory

$794.90K
SXTC annual inventory is $794.90 thousand

Liabilities

Total liabilities

$9.20M
SXTC annual total liabilities is $9.20 million

Long term liabilities

$294.70K
SXTC annual total long term liabilities is $294.70 thousand

Current liabilities

$8.90M
SXTC annual total current liabilities is $8.90 million

Accounts payable

$1.28M
SXTC annual accounts payable is $1.28 million

Debt

Total debt

$2.65M
SXTC annual total debt is $2.65 million

Total debt 1-year change

-29.53%
SXTC annual total debt is down -29.53% year-on-year

Long term debt

$294.70K
SXTC annual long term debt is $294.70 thousand

Short term debt

$2.35M
SXTC annual short term debt is $2.35 million

Equity & Capital

Shareholders equity

$13.93M
SXTC annual stockholders equity is $13.93 million

Book value

$13.93M
SXTC annual book value is $13.93 million

Retained earnings

-$24.71M
SXTC annual retained earnings is -$24.71 million

Working capital

$5.33M
SXTC annual working capital is $5.33 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$1.93M
SXTC annual cash flow from operations is -$1.93 million

Cash from operations 1-year change

-2286.26%
SXTC annual cash flow from operations is down -2286.26% year-on-year

Cash from investing

$26.40K
SXTC annual cash flow from investing activities is $26.40 thousand

Cash from investing 1-year change

+314.63%
SXTC annual cash flow from investing activities is up +314.63% year-on-year

Cash from financing

-$2.62M
SXTC annual cash flow from financing activities is -$2.62 million

Cash from financing 1-year change

-189.22%
SXTC annual cash flow from financing activities is down -189.22% year-on-year

CAPEX

CAPEX

$7100.00
SXTC annual capital expenditures is $7100.00

CAPEX 1-year change

-89.96%
SXTC annual capital expenditures is down -89.96% year-on-year

Free Cash Flow

Free cash flow

-$1.94M
SXTC annual free cash flow is -$1.94 million

Free cash flow 1-year change

-1178.14%
SXTC annual free cash flow is down -1178.14% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

28.73%
SXTC annual gross profit margin is 28.73%

Operating margin

-130.42%
SXTC annual operating profit margin is -130.42%

Net margin

-160.67%
SXTC annual net profit margin is -160.67%

ROA & ROE

ROA

-11.76%
SXTC annual return on assets is -11.76%

ROE

-21.65%
SXTC annual return on equity is -21.65%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
SXTC price to earnings ratio value is unknown

PE ratio Sector rank

-
SXTC price to earnings ratio is unknown

PB Ratio

PB ratio

2.92
SXTC price to book ratio is 2.92

PB ratio Sector rank

71.72%
SXTC price to book ratio is higher than 71.72% of companies in Healthcare sector

PS Ratio

PS ratio

-
SXTC price to sales ratio value is unknown

PS ratio Sector rank

-
SXTC price to sales ratio is unknown

Enterprise value

Enterprise value

-
SXTC enterprise value value is unknown

Enterprise value Sector rank

-
SXTC enterprise value is unknown

EV/EBITDA

EV/EBITDA

-
SXTC EV/EBITDA value is unknown

EV/EBITDA Sector rank

-
SXTC EV/EBITDA is unknown

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

1.60
SXTC annual current ratio is 1.60

Quick ratio

1.51
SXTC annual quick ratio is 1.51

Leverage

Debt to equity

0.17
SXTC annual debt to equity ratio is 0.17

Interest coverage ratio

-4.69
SXTC annual interest coverage ratio is -4.69

Risk & Stability

Piotroski F-Score

-
SXTC piotroski f-score value is unknown

Altman Z-Score

0.44
SXTC altman z-score is 0.44

Analyst ratings

Recent major analysts updates

No data about analysts updates

Institutional Ownership

Similar stocks

AKTX logo
Akari Therapeutics (AKTX)
ALLK logo
Allakos (ALLK)
CASI logo
CASI Pharmaceuticals (CASI)
ALXO logo
ALX Oncology Holdings (ALXO)
PIII logo
P3 Health Partners (PIII)
KZR logo
Kezar Life Sciences (KZR)
FGEN logo
FibroGen (FGEN)
INKT logo
MiNK Therapeutics (INKT)
BNR logo
Burning Rock Biotech Limited (BNR)
  • What is the ticker symbol for China SXT Pharmaceuticals?
  • Does China SXT Pharmaceuticals pay dividends?
  • What sector is China SXT Pharmaceuticals in?
  • What industry is China SXT Pharmaceuticals in?
  • What country is China SXT Pharmaceuticals based in?
  • When did China SXT Pharmaceuticals go public?
  • Is China SXT Pharmaceuticals in the S&P 500?
  • Is China SXT Pharmaceuticals in the NASDAQ 100?
  • Is China SXT Pharmaceuticals in the Dow Jones?
  • When was China SXT Pharmaceuticals's last earnings report?
  • When does China SXT Pharmaceuticals report earnings?

What is the ticker symbol for China SXT Pharmaceuticals?

The ticker symbol for China SXT Pharmaceuticals is NASDAQ:SXTC

Does China SXT Pharmaceuticals pay dividends?

No, China SXT Pharmaceuticals does not pay dividends

What sector is China SXT Pharmaceuticals in?

China SXT Pharmaceuticals is in the Healthcare sector

What industry is China SXT Pharmaceuticals in?

China SXT Pharmaceuticals is in the Drug Manufacturers - Specialty & Generic industry

What country is China SXT Pharmaceuticals based in?

China SXT Pharmaceuticals is headquartered in China

When did China SXT Pharmaceuticals go public?

China SXT Pharmaceuticals's initial public offering (IPO) was on January 4, 2019

Is China SXT Pharmaceuticals in the S&P 500?

No, China SXT Pharmaceuticals is not included in the S&P 500 index

Is China SXT Pharmaceuticals in the NASDAQ 100?

No, China SXT Pharmaceuticals is not included in the NASDAQ 100 index

Is China SXT Pharmaceuticals in the Dow Jones?

No, China SXT Pharmaceuticals is not included in the Dow Jones index

When was China SXT Pharmaceuticals's last earnings report?

China SXT Pharmaceuticals's most recent earnings report was on Apr 5, 2024

When does China SXT Pharmaceuticals report earnings?

The date for China SXT Pharmaceuticals's next earnings report has not been announced yet
On this page